|
The Centers for Medicare & Medicaid Services (CMS) issued a national coverage decision (NCD) to extend coverage for the home use of oxygen to Medicare beneficiaries enrolled in a CMS approved clinical trial sponsored by the National Heart, Lung & Blood Institute (NHLBI). Medicare currently provides coverage for home oxygen for beneficiaries with partial pressure measurements at or below 55 mmHg or oxygen saturation at or below 88%. If specified other diseases/conditions are present, coverage is provided for patients with higher oxygen levels under certain circumstances. The trial will include Medicare beneficiaries with arterial oxygen partial measurements from 56 to 65 mmHg or whose oxygen saturation is at or above 89% who do not meet the current Medicare coverage requirements for home oxygen. More information on the trial will be posted later this year.
Page Last Modified: 05/27/2008 7:44:32 AM
Help with File Formats and Plug-Ins
Submit Feedback
|
Email
Print